title: Foreword.
authors.forename: Helen X
authors.initials: HX
authors.lastname: Chen
authors.forename: Jessica N
authors.initials: JN
authors.lastname: Cleck
authors.forename: Rochelle
authors.initials: R
authors.lastname: Coelho
authors.forename: Janet E
authors.initials: JE
authors.lastname: Dancey
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000037:antagonists & inhibitors / Q000502:physiology; D016503:Drug Delivery Systems; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000502:physiology; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000209:etiology; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000502:physiology
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D066246:ErbB Receptors; D047428:Protein Kinase Inhibitors; D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human